The anti-inflammatory effects of GLP-1 agonists may have broader implications for disease management and fertility outcomes as persistent low-grade inflammation is believed to be a trigger in the development of PCOS [16]. The gene discussed is GCG; the disease is polycystic ovary syndrome.